RecruitingNCT07059026
Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients
Studying Thrombotic microangiopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ITAC (Instituto de Trasplantes y Alta Complejidad)
- Enrollment
- 200 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Instituto de Trasplantes de Alta Complejidad (ITAC), Buenos Aires, Argentina
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07059026 on ClinicalTrials.govOther trials for Thrombotic microangiopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06102694Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic MicroangiopathyInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE4NCT05743400Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell TransplantationHospices Civils de Lyon
- RECRUITINGNCT06759961Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant CentreIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGPHASE3NCT04543591Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantAlexion Pharmaceuticals, Inc.